Resource Center: buprenorphine, dependence

This guide is designed to give family physicians information to help understand, implement, and interpret Urine Drug Tests (UDT's) in their practices. Authors: Gourlay D, Heit HA, Caplan YH As of April 2010, Edition 3 was no longer available and the 4th Edition was in preparation.

This Treatment Improvement Protocol (TIP), Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, provides consensus‐ and evidence‐based treatment guidance for the use of buprenorphine, a new option for the treatment of opioid addiction. The goal of this TIP is to provide physicians with information they can use to make practical and informed decisions about the use of buprenorphine to treat opioid addiction. These guidelines address the pharmacology and physiology of opioids, opioid addiction, and treatment with buprenorphine; describe patient assessment and the choice of opioid addiction treatment options; provide detailed treatment protocols for opioid withdrawal and maintenance therapy with buprenorphine; and include information on the treatment of special populations, e.g., pregnant women, adolescents, and polysubstance users. This TIP represents another step by the Center for Substance Abuse Treatment (CSAT) toward its goal of bringing national leaders together to improve substance use disorder treatment in the United States. (From Their Website)

This is the American Society of Addiction Medicine's member directory which allows users to search by physician first name, last name, city, state, and specialty to find ASAM certified providers.

The American Psychiatric Association has released practice guidelines and resources for the treatment of patients with substance use disorders.

The American Society of Addiction Medicine (ASAM) is an organization dedicated to increase access to and improve the quality of addiction treatment, educate physicians (including medical students and osteopathic students), other health care providers and the public, to support research and prevention, to promote the appropriate role of the physician in the care of patients with addiction, and to establish addiction medicine as a specialty (From their Website).

Symptoms, Red Flags, and Risk Factors of Abuse/Dependence informational page

A site for physicians, researchers, pharmacists, nurses, and counselors to learn more about buprenorphine as a medication for opioid addiction treatment.

Subutex (buprenorphine hydrochloride) and Suboxone tablets (buprenorphine hydrochloride and naloxone hydrochloride) is approved for the treatment of opiate dependence. Subutex and Suboxone treat opiate addiction by preventing symptoms of withdrawal from heroin and other opiates. (From Their Website)

This is the website of Narcotics Anonymous, an international, community-based association of recovering drug addicts.

Lists the qualifying criteria for primary care physicians to administer buprenorphine.